Semaglutide/Cyanocobalamin 24/2 MG/ML Injectable, 0.4 ML syringe, Rx only, Carolina Infusion LLC,...

FDA Drug Recall #D-1521-2022 — Class II — August 26, 2022

Recall Summary

Recall Number D-1521-2022
Classification Class II — Moderate risk
Date Initiated August 26, 2022
Status Completed
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Carolina Infusion
Location Ridgeland, SC
Product Type Drugs
Quantity 4 syringes

Product Description

Semaglutide/Cyanocobalamin 24/2 MG/ML Injectable, 0.4 ML syringe, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936.

Reason for Recall

Lack of Assurance of Sterility

Distribution Pattern

Nationwide in the USA.

Lot / Code Information

Lot: 08172022@1 BUD: 09/16/2022

Other Recalls from Carolina Infusion

Recall # Classification Product Date
D-1517-2022 Class II MIC/B12/L-Carn (HD) 35/35/35/1/35 MG/ML Injecta... Aug 26, 2022
D-1524-2022 Class II TEST CYP/DHEA (Sesame) 200 MG/2.5 MG/ML Injecta... Aug 26, 2022
D-1533-2022 Class II QUAD-MIX 30/2/60/0.15 Injectable, 5 ML vial, Rx... Aug 26, 2022
D-1522-2022 Class II TEST CYP (Grapeseed) 200 MG/ML Injectable, 10 M... Aug 26, 2022
D-1516-2022 Class II MIC/B12 25/50/50/1 MG/ML Injectable, 10 ML vial... Aug 26, 2022

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.